Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.
2.

Biopolymer-based biomaterials for accelerated diabetic wound healing: A critical review.

Shah SA, Sohail M, Khan S, Minhas MU, de Matas M, Sikstone V, Hussain Z, Abbasi M, Kousar M.

Int J Biol Macromol. 2019 Oct 15;139:975-993. doi: 10.1016/j.ijbiomac.2019.08.007. Epub 2019 Aug 3. Review.

PMID:
31386871
3.

PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.

Hussain Z, Khan S, Imran M, Sohail M, Shah SWA, de Matas M.

Drug Deliv Transl Res. 2019 Jun;9(3):721-734. doi: 10.1007/s13346-019-00631-4. Review.

PMID:
30895453
4.

Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction.

Ndlovu ST, Ullah N, Khan S, Ramharack P, Soliman M, de Matas M, Shahid M, Sohail M, Imran M, Shah SWA, Hussain Z.

Drug Deliv Transl Res. 2019 Feb;9(1):284-297. doi: 10.1007/s13346-018-00596-w.

PMID:
30387048
5.

Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects.

Sohail M, Mudassir, Minhas MU, Khan S, Hussain Z, de Matas M, Shah SA, Khan S, Kousar M, Ullah K.

Drug Deliv Transl Res. 2019 Apr;9(2):595-614. doi: 10.1007/s13346-018-0512-x. Review.

PMID:
29611113
6.

Dexibuprofen nanocrystals with improved therapeutic performance: fabrication, characterization, in silico modeling, and in vivo evaluation.

Ullah N, Khan S, Ahmed S, Govender T, Faidah HS, de Matas M, Shahid M, Minhas MU, Sohail M, Khurram M.

Int J Nanomedicine. 2018 Mar 20;13:1677-1692. doi: 10.2147/IJN.S151597. eCollection 2018.

7.

Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.

Marzan AL, Tabassum R, Jahan B, Asif MH, Reza HM, Kazi M, Alshehri SM, de Matas M, Shariare MH.

Curr Drug Deliv. 2018;15(5):672-685. doi: 10.2174/1567201815666180123094320.

PMID:
29359667
8.

How to interpret elevated plasmatic level of high-sensitive troponin T in newborns and infants?

Jehlicka P, Huml M, Rajdl D, Mockova A, Matas M, Dort J, Masopustova A.

Physiol Res. 2018 May 4;67(2):191-195. Epub 2018 Jan 5.

9.

Emerging Trends in Therapeutic Algorithm of Chronic Wound Healers: Recent Advances in Drug Delivery Systems, Concepts-to-Clinical Application and Future Prospects.

Shao M, Hussain Z, Thu HE, Khan S, de Matas M, Silkstone V, Qin HL, Bukhari SNA.

Crit Rev Ther Drug Carrier Syst. 2017;34(5):387-452. doi: 10.1615/CritRevTherDrugCarrierSyst.2017016957. Review.

PMID:
29256838
10.

The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia.

Rushmi ZT, Akter N, Mow RJ, Afroz M, Kazi M, de Matas M, Rahman M, Shariare MH.

Saudi Pharm J. 2017 Mar;25(3):404-412. doi: 10.1016/j.jsps.2016.09.011. Epub 2016 Oct 1.

11.

Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation.

Shah SM, Ullah F, Khan S, Shah SM, de Matas M, Hussain Z, Minhas MU, AbdEl-Salam NM, Assi KH, Isreb M.

Drug Des Devel Ther. 2016 Nov 24;10:3837-3850. eCollection 2016.

12.

Strategic framework for education and training in Quality by Design (QbD) and process analytical technology (PAT).

de Matas M, De Beer T, Folestad S, Ketolainen J, Lindén H, Lopes JA, Oostra W, Weimer M, Öhrngren P, Rantanen J.

Eur J Pharm Sci. 2016 Jul 30;90:2-7. doi: 10.1016/j.ejps.2016.04.024. Epub 2016 Apr 23.

PMID:
27112991
13.

Asymmetric distribution in twin screw granulation.

Chan Seem T, Rowson NA, Gabbott I, de Matas M, Reynolds GK, Ingram A.

Eur J Pharm Biopharm. 2016 Sep;106:50-8. doi: 10.1016/j.ejpb.2016.01.013. Epub 2016 Jan 25.

PMID:
26820919
14.

Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.

Trucco E, Tolosana JM, Castel MÁ, Batlle M, Borràs R, Sitges M, Guash E, Matas M, Arbelo E, Berruezo A, Brugada J, Mont L.

Europace. 2016 Feb;18(2):232-7. doi: 10.1093/europace/euv054. Epub 2015 Apr 16.

PMID:
25883077
15.

Relating the outcome of HCV infection and different host SNP polymorphisms in a Majorcan population coinfected with HCV-HIV and treated with pegIFN-RBV.

Matas M, Picornell A, Cifuentes C, Payeras A, Homar F, González-Candelas F, López-Labrador FX, Moya A, Ramon C, Castro JA.

Int Microbiol. 2014 Mar;17(1):11-20.

16.

Granulation of increasingly hydrophobic formulations using a twin screw granulator.

Yu S, Reynolds GK, Huang Z, de Matas M, Salman AD.

Int J Pharm. 2014 Nov 20;475(1-2):82-96. doi: 10.1016/j.ijpharm.2014.08.015. Epub 2014 Aug 12.

PMID:
25124058
17.

Transfer from high-shear batch to continuous twin screw wet granulation: a case study in understanding the relationship between process parameters and product quality attributes.

Beer P, Wilson D, Huang Z, De Matas M.

J Pharm Sci. 2014 Oct;103(10):3075-82. doi: 10.1002/jps.24078. Epub 2014 Jul 8.

PMID:
25044074
18.

EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors.

Khatib M, Tolosana JM, Trucco E, Borràs R, Castel A, Berruezo A, Doltra A, Sitges M, Arbelo E, Matas M, Brugada J, Mont L.

Eur J Heart Fail. 2014 Jul;16(7):802-9. doi: 10.1002/ejhf.102. Epub 2014 May 23.

19.

Asymptomatic carotid stenosis and cognitive improvement using transcervical stenting with protective flow reversal technique.

Ortega G, Alvarez B, Quintana M, Yugueros X, Alvarez-Sabin J, Matas M.

Eur J Vasc Endovasc Surg. 2014 Jun;47(6):585-92. doi: 10.1016/j.ejvs.2014.02.022. Epub 2014 Apr 14.

20.

Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy.

Arbelo E, Tolosana JM, Trucco E, Penela D, Borràs R, Doltra A, Andreu D, Aceña M, Berruezo A, Sitges M, Mansour F, Castel A, Matas M, Brugada J, Mont L.

J Cardiovasc Electrophysiol. 2014 Mar;25(3):283-92. doi: 10.1111/jce.12322. Epub 2013 Dec 16.

PMID:
24237881
21.

Quantification of swelling and erosion in the controlled release of a poorly water-soluble drug using synchrotron X-ray computed microtomography.

Yin X, Li H, Guo Z, Wu L, Chen F, de Matas M, Shao Q, Xiao T, York P, He Y, Zhang J.

AAPS J. 2013 Oct;15(4):1025-34. doi: 10.1208/s12248-013-9498-y. Epub 2013 Jul 16.

22.

Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.

Tolosana JM, Trucco E, Khatib M, Doltra A, Borras R, Castel MÁ, Berruezo A, Arbelo E, Sitges M, Matas M, Guasch E, Brugada J, Mont L.

Eur J Heart Fail. 2013 Dec;15(12):1412-8. doi: 10.1093/eurjhf/hft114. Epub 2013 Jul 11.

23.

Reduction of halo pin site morbidity with a new pin care regimen.

Kazi HA, de Matas M, Pillay R.

Asian Spine J. 2013 Jun;7(2):91-5. doi: 10.4184/asj.2013.7.2.91. Epub 2013 May 22.

24.

Cognitive improvement in patients with severe carotid artery stenosis after transcervical stenting with protective flow reversal.

Ortega G, Álvarez B, Quintana M, Ribó M, Matas M, Alvarez-Sabin J.

Cerebrovasc Dis. 2013;35(2):124-30. doi: 10.1159/000346102. Epub 2013 Feb 7.

PMID:
23406878
25.

Compressive symptoms due to thrombosed or hypertrophic collateral circulation in infrarenal inferior vena cava agenesis.

Yugueros X, Alvarez B, Fernández E, Boqué M, Matas M.

Ann Vasc Surg. 2013 Feb;27(2):238.e9-238.e13. doi: 10.1016/j.avsg.2012.06.014.

PMID:
23380553
26.

Antiplatelet therapy in endovascular surgery: the RENDOVASC study.

Matas M, Domínguez González JM, Montull E.

Ann Vasc Surg. 2013 Feb;27(2):168-77. doi: 10.1016/j.avsg.2011.11.045.

PMID:
23380550
27.

Generalized Linear Model (GLM) framework for the association of host variables and viral strains with liver fibrosis in HCV/HIV coinfected patients.

Matas M, Picornell A, Cifuentes C, Payeras A, Bassa A, Homar F, González-Candelas F, López-Labrador FX, Moya A, Ramon MM, Castro JA.

Infect Genet Evol. 2013 Jan;13:284-91. doi: 10.1016/j.meegid.2012.10.020. Epub 2012 Nov 19.

PMID:
23174528
28.

Quality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compression.

Aksu B, Paradkar A, de Matas M, Ozer O, Güneri T, York P.

AAPS PharmSciTech. 2012 Dec;13(4):1138-46. doi: 10.1208/s12249-012-9836-x. Epub 2012 Sep 6.

29.

A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation.

Aksu B, Paradkar A, de Matas M, Özer Ö, Güneri T, York P.

Pharm Dev Technol. 2013 Feb;18(1):236-45. doi: 10.3109/10837450.2012.705294. Epub 2012 Aug 13.

PMID:
22881350
30.

Unusual presentation of tuberculosis with multiple spinal deposits.

Dahab R, Barrett C, Dunn A, De Matas M, Pillay R.

Br J Neurosurg. 2012 Dec;26(6):925-6. doi: 10.3109/02688697.2012.697222. Epub 2012 Jul 12.

PMID:
22788774
31.

Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).

Aksu B, De Beer T, Folestad S, Ketolainen J, Lindén H, Lopes JA, de Matas M, Oostra W, Rantanen J, Weimer M.

Eur J Pharm Sci. 2012 Sep 29;47(2):402-5. doi: 10.1016/j.ejps.2012.06.009. Epub 2012 Jun 26.

PMID:
22749874
32.

Innominate artery aneurysm with hemoptysis and airway compression in a patient with bovine aortic arch.

Constenla I, Alvarez B, Yugueros X, Fernandez E, Bofill R, Matas M.

J Vasc Surg. 2012 Sep;56(3):822-5. doi: 10.1016/j.jvs.2012.03.241. Epub 2012 Jun 23.

33.

Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.

Fernández-Armenta J, Berruezo A, Mont L, Sitges M, Andreu D, Silva E, Ortiz-Pérez JT, Tolosana JM, de Caralt TM, Perea RJ, Calvo N, Trucco E, Borràs R, Matas M, Brugada J.

Europace. 2012 Nov;14(11):1578-86. doi: 10.1093/europace/eus104. Epub 2012 May 4.

PMID:
22562658
34.

Relationship between plasma homocysteine and the morphological and immunohistochemical study of carotid plaques in patients with carotid stenosis over 70%.

Alvarez B, Yugueros X, Fernández E, Luccini F, Gené A, Matas M.

Ann Vasc Surg. 2012 May;26(4):500-5. doi: 10.1016/j.avsg.2011.05.047.

PMID:
22520390
35.

Anterior thigh compartment syndrome after prone positioning for lumbosacral fixation.

Dahab R, Barrett C, Pillay R, De Matas M.

Eur Spine J. 2012 Jun;21 Suppl 4:S554-6. doi: 10.1007/s00586-012-2282-3. Epub 2012 Apr 7.

36.

Transcervical carotid stenting with flow reversal is a safe technique for high-risk patients older than 70 years.

Alvarez B, Matas M, Ribo M, Maeso J, Yugueros X, Alvarez-Sabin J.

J Vasc Surg. 2012 Apr;55(4):978-84. doi: 10.1016/j.jvs.2011.10.084. Epub 2012 Feb 7.

37.

Influence of solvent on the morphology and subsequent comminution of ibuprofen crystals by air jet milling.

Shariare MH, Blagden N, de Matas M, Leusen FJ, York P.

J Pharm Sci. 2012 Mar;101(3):1108-19. doi: 10.1002/jps.23003. Epub 2011 Dec 7.

PMID:
22161641
38.

Intracorneal hemorrhage in 19 dogs (22 eyes) from 2000 to 2010: a retrospective study.

Matas M, Donaldson D, Newton RJ.

Vet Ophthalmol. 2012 Mar;15(2):86-91. doi: 10.1111/j.1463-5224.2011.00944.x. Epub 2011 Nov 29.

PMID:
22129068
39.

Improved outcomes and complications of atrial fibrillation catheter ablation over time: learning curve, techniques, and methodology.

Calvo N, Nadal M, Berruezo A, Andreu D, Arbelo E, Tolosana JM, Guasch E, Matiello M, Matas M, Alsina X, Sitges M, Brugada J, Mont L.

Rev Esp Cardiol (Engl Ed). 2012 Feb;65(2):131-8. doi: 10.1016/j.recesp.2011.08.015. Epub 2011 Nov 25. English, Spanish.

PMID:
22118728
40.

Characterization of thermal and rheological properties of zidovudine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion.

Maru SM, de Matas M, Kelly A, Paradkar A.

Eur J Pharm Sci. 2011 Nov 20;44(4):471-8. doi: 10.1016/j.ejps.2011.09.003. Epub 2011 Sep 10.

PMID:
21925600
41.

Prediction of the mechanical behaviour of crystalline solids.

Shariare MH, Leusen FJ, de Matas M, York P, Anwar J.

Pharm Res. 2012 Jan;29(1):319-31. doi: 10.1007/s11095-011-0543-1. Epub 2011 Aug 16.

PMID:
21845506
42.

Comminution of ibuprofen to produce nano-particles for rapid dissolution.

Plakkot S, de Matas M, York P, Saunders M, Sulaiman B.

Int J Pharm. 2011 Aug 30;415(1-2):307-14. doi: 10.1016/j.ijpharm.2011.06.002. Epub 2011 Jun 12.

PMID:
21683776
43.

Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate.

Shariare MH, de Matas M, York P.

Int J Pharm. 2011 Aug 30;415(1-2):62-72. doi: 10.1016/j.ijpharm.2011.05.043. Epub 2011 Jun 12.

PMID:
21683128
44.

Electrocardiographic versus echocardiographic optimization of the interventricular pacing delay in patients undergoing cardiac resynchronization therapy.

Tamborero D, Vidal B, Tolosana JM, Sitges M, Berruezo A, Silva E, Castel M, Matas M, Arbelo E, Rios J, Villacastín J, Brugada J, Mont L.

J Cardiovasc Electrophysiol. 2011 Oct;22(10):1129-34. doi: 10.1111/j.1540-8167.2011.02085.x. Epub 2011 Jun 2.

PMID:
21635609
45.

The impact of material attributes and process parameters on the micronisation of lactose monohydrate.

Shariare MH, de Matas M, York P, Shao Q.

Int J Pharm. 2011 Apr 15;408(1-2):58-66. doi: 10.1016/j.ijpharm.2011.01.047. Epub 2011 Feb 2.

PMID:
21295125
46.

Predicting the clinical effect of a short acting bronchodilator in individual patients using artificial neural networks.

de Matas M, Shao Q, Biddiscombe MF, Meah S, Chrystyn H, Usmani OS.

Eur J Pharm Sci. 2010 Dec 23;41(5):707-15. doi: 10.1016/j.ejps.2010.09.018. Epub 2010 Oct 12.

PMID:
20932900
47.

Unilateral eyelid lesion and ophthalmologic findings in an aardvark (Orycteropus afer): case report and literature review.

Matas M, Wise I, Masters NJ, Stewart J, Holloway A, Donaldson D, Hartley C.

Vet Ophthalmol. 2010 Sep;13 Suppl:116-22. doi: 10.1111/j.1463-5224.2010.00803.x. Review.

PMID:
20840100
48.

Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients.

Matas M, Picornell A, Cifuentes C, Payeras A, Bassa A, Homar F, López-Labrador FX, Moya A, Ramon MM, Castro JA.

Infect Genet Evol. 2010 Dec;10(8):1252-61. doi: 10.1016/j.meegid.2010.08.009. Epub 2010 Aug 21.

PMID:
20732459
49.

Design of a fixed-dose paediatric combination of artesunate and amodiaquine hydrochloride.

Okwelogu C, Clark B, de Matas M, Ifudu D, Igwilo C, Silva B, York P.

Int J Pharm. 2010 Mar 15;387(1-2):19-25. doi: 10.1016/j.ijpharm.2009.11.028. Epub 2009 Dec 2.

PMID:
19961911
50.

Endovascular treatment of traumatic thoracic aortic injuries: short- and medium-term Follow-up.

Fernandez V, Mestres G, Maeso J, Domínguez JM, Aloy MC, Matas M.

Ann Vasc Surg. 2010 Feb;24(2):160-6. doi: 10.1016/j.avsg.2009.05.013. Epub 2009 Nov 8.

PMID:
19900782

Supplemental Content

Support Center